115 related articles for article (PubMed ID: 10209727)
1. Regulation of intraocular pressure after water drinking.
Brucculeri M; Hammel T; Harris A; Malinovsky V; Martin B
J Glaucoma; 1999 Apr; 8(2):111-6. PubMed ID: 10209727
[TBL] [Abstract][Full Text] [Related]
2. Effect of MK-507 on aqueous humor dynamics in normal human eyes.
Yamazaki Y; Miyamoto S; Sawa M
Jpn J Ophthalmol; 1994; 38(1):92-6. PubMed ID: 7933704
[TBL] [Abstract][Full Text] [Related]
3. Effects of ocular administration of ophthalmic 2% dorzolamide hydrochloride solution on aqueous humor flow rate and intraocular pressure in clinically normal cats.
Rankin AJ; Crumley WR; Allbaugh RA
Am J Vet Res; 2012 Jul; 73(7):1074-8. PubMed ID: 22738060
[TBL] [Abstract][Full Text] [Related]
4. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.
Gudmundsdóttir E; Stefánsson E; Bjarnadóttir G; Sigurjónsdóttir JF; Gudmundsdóttir G; Masson M; Loftsson T
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of exercise-induced ocular hypotension.
Martin B; Harris A; Hammel T; Malinovsky V
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):1011-5. PubMed ID: 10102302
[TBL] [Abstract][Full Text] [Related]
6. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
7. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.
Gugleta K; Orgül S; Flammer J
Curr Med Res Opin; 2003; 19(4):330-5. PubMed ID: 12841926
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
[TBL] [Abstract][Full Text] [Related]
9. Results of the European Glaucoma Prevention Study.
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
[TBL] [Abstract][Full Text] [Related]
10. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.
Crowston JG; Lindsey JD; Morris CA; Wheeler L; Medeiros FA; Weinreb RN
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4571-7. PubMed ID: 16303950
[TBL] [Abstract][Full Text] [Related]
11. A randomized study of dorzolamide in the prevention of elevated intraocular pressure after anterior segment laser surgery. Dorzolamide Laser Study Group.
Hartenbaum D; Wilson H; Maloney S; Vacarelli L; Orillac R; Sharpe E
J Glaucoma; 1999 Aug; 8(4):273-5. PubMed ID: 10464738
[TBL] [Abstract][Full Text] [Related]
12. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
13. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
[TBL] [Abstract][Full Text] [Related]
14. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
15. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
Strohmaier K; Snyder E; DuBiner H; Adamsons I
Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
[TBL] [Abstract][Full Text] [Related]
17. Effects of topical administration of 1% brinzolamide on intraocular pressure in clinically normal horses.
Germann SE; Matheis FL; Rampazzo A; Burger D; Roos M; Spiess BM
Equine Vet J; 2008 Nov; 40(7):662-5. PubMed ID: 18487097
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
Sharir M; Pierce WM; Chen D; Zimmerman TJ
Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
[TBL] [Abstract][Full Text] [Related]
19. [Effect of topical carbonic anhydrase inhibitor (MK-507) on intraocular pressure of normal human eyes].
Yamazaki Y; Miyamoto S; Sawa M
Nippon Ganka Gakkai Zasshi; 1994 Mar; 98(3):293-7. PubMed ID: 8154389
[TBL] [Abstract][Full Text] [Related]
20. Dorzolamide influences the autoregulation of major retinal vessels caused by artificial intraocular pressure elevation in patients with POAG: a clinical study.
Nagel E; Vilser W; Lanzl I
Curr Eye Res; 2005 Feb; 30(2):129-37. PubMed ID: 15814471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
